NCT00200343View on ClinicalTrials.gov

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

596

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

December 31, 2004

Conditions
Chronic Hepatitis C
Interventions
DRUG

Ursodeoxycholic acid 150mg / day

Ursodeoxycholic acid, 150mg/ day, three times a day at meals

DRUG

Ursodeoxycholic acid 600mg / day

Ursodeoxycholic acid, 600mg/ day, three times a day at meals

DRUG

Ursodeoxycholic acid 900mg / day

Ursodeoxycholic acid, 900mg/ day, three times a day at meals

Trial Locations (1)

Unknown

Department of Gastroenterology, University of Tokyo, Hongo, Bunkyo-ku, Tokyo

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY